within the fast evolving industry of cancer therapeutics, understanding the intricate mechanisms of Antibody-Drug Conjugates (ADCs) is very important for creating effective remedies. The most promising approaches is using in vitro bystander impact assays, which play a pivotal position in boosting therapeutic efficacy. These assays, provided by firm… Read More